Pharmaceutical Technologist - September 2007 - (Page 37) TOGETHER Excipients That Constantly Hit The Mark For Your Drug Delivery Applications At AsahiKASEI we believe that through constant innovation and advances based in science, we will always be at the forefront of contributing to human life and livelihood. By creating value and working in close unison with our customers, together we can target success. Ceolus® Ceolus® KG-802 is an MCC dry binder with a distinctive rod-form particle configuration that is ideal for tableting of low-compactible drugs or coated granules. It is very effective for reducing the tablet size of large doses. Celphere® Celphere® is a 100% MCC seed core that is used for drug layering and film coating. PCS® A versatile excipient, PCS® is a non-soluble pregelatinized starch with an extremely low water-soluble content. Trehalose A non-reducing disaccharide, Trehalose provides functions such as low reactivity with drugs. Kiccolate® Kiccolate® is a Croscarmellose sodium (Non-GMO) which is known as a super disintegrant. AsahiKASEI together we can achieve success. ASAHI KASEI AMERICA, INC., 535 Madison Avenue, 33rd Floor New York, NY 10022, USA P (212) 371-9900 Ext. 217 F (212) 371-9050 www.ceolus.com http://www.ceolus.com http://www.ceolus.com
Table of Contents Feed for the Digital Edition of Pharmaceutical Technologist - September 2007 Contents Editor’s Comment News Morpheus Market Watch CPhI Worldwide 2007 Compliant Pharmaceutical Labelling Q&A Pharmaceutical Technologist - September 2007 Pharmaceutical Technologist - September 2007 - (Page 1) Pharmaceutical Technologist - September 2007 - (Page 2) Pharmaceutical Technologist - September 2007 - Contents (Page 3) Pharmaceutical Technologist - September 2007 - Editor’s Comment (Page 4) Pharmaceutical Technologist - September 2007 - Editor’s Comment (Page 5) Pharmaceutical Technologist - September 2007 - News (Page 6) Pharmaceutical Technologist - September 2007 - News (Page 7) Pharmaceutical Technologist - September 2007 - News (Page 8) Pharmaceutical Technologist - September 2007 - News (Page 9) Pharmaceutical Technologist - September 2007 - Morpheus (Page 10) Pharmaceutical Technologist - September 2007 - Morpheus (Page 11) Pharmaceutical Technologist - September 2007 - Morpheus (Page 12) Pharmaceutical Technologist - September 2007 - Morpheus (Page 13) Pharmaceutical Technologist - September 2007 - Market Watch (Page 14) Pharmaceutical Technologist - September 2007 - Market Watch (Page 15) Pharmaceutical Technologist - September 2007 - Market Watch (Page 16) Pharmaceutical Technologist - September 2007 - Market Watch (Page 17) Pharmaceutical Technologist - September 2007 - CPhI Worldwide 2007 (Page 18) Pharmaceutical Technologist - September 2007 - CPhI Worldwide 2007 (Page 19) Pharmaceutical Technologist - September 2007 - CPhI Worldwide 2007 (Page 20) Pharmaceutical Technologist - September 2007 - CPhI Worldwide 2007 (Page 21) Pharmaceutical Technologist - September 2007 - CPhI Worldwide 2007 (Page 22) Pharmaceutical Technologist - September 2007 - CPhI Worldwide 2007 (Page 23) Pharmaceutical Technologist - September 2007 - CPhI Worldwide 2007 (Page 24) Pharmaceutical Technologist - September 2007 - CPhI Worldwide 2007 (Page 25) Pharmaceutical Technologist - September 2007 - Compliant Pharmaceutical Labelling (Page 26) Pharmaceutical Technologist - September 2007 - Compliant Pharmaceutical Labelling (Page 27) Pharmaceutical Technologist - September 2007 - Compliant Pharmaceutical Labelling (Page 28) Pharmaceutical Technologist - September 2007 - Compliant Pharmaceutical Labelling (Page 29) Pharmaceutical Technologist - September 2007 - Q&A (Page 30) Pharmaceutical Technologist - September 2007 - Q&A (Page 31) Pharmaceutical Technologist - September 2007 - Q&A (Page 32) Pharmaceutical Technologist - September 2007 - Q&A (Page 33) Pharmaceutical Technologist - September 2007 - Q&A (Page 34) Pharmaceutical Technologist - September 2007 - Q&A (Page 35) Pharmaceutical Technologist - September 2007 - Q&A (Page 36) Pharmaceutical Technologist - September 2007 - Q&A (Page 37)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.